{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:47:22Z","timestamp":1789004842499,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/gast.2001.27965","type":"journal-article","created":{"date-parts":[[2005,7,29]],"date-time":"2005-07-29T17:58:00Z","timestamp":1122659880000},"page":"900-907","source":"Crossref","is-referenced-by-count":288,"title":["A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis"],"prefix":"10.1053","volume":"121","author":[{"given":"Stephen A.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davinder S.","family":"Bansi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Von","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/gast.2001.27965_bib1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"10.1053\/gast.2001.27965_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0025-6196(12)60897-0","article-title":"Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis","volume":"68","author":"Hashimoto","year":"1993","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/gast.2001.27965_bib3","first-page":"S20","article-title":"Activated lymphocytes in the liver of patients with primary sclerosing cholangitis: results of a morphometric study","volume":"35","author":"Martins","year":"1994","journal-title":"Gut"},{"key":"10.1053\/gast.2001.27965_bib4","first-page":"A757","article-title":"Enhanced Cytokine mRNA expression in primary sclerosing cholangitis and autoimmune liver disease","volume":"112","author":"Mitchell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.35.1.84","article-title":"Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm","volume":"35","author":"Broom\u00e9","year":"1994","journal-title":"Gut"},{"key":"10.1053\/gast.2001.27965_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"10.1053\/gast.2001.27965_bib7","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/0016-5085(92)91449-E","article-title":"Primary sclerosing cholangitis: refinement and validation of survival models","volume":"103","author":"Dickson","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0168-8278(05)80618-X","article-title":"Risk factors in primary sclerosing cholangitis","volume":"21","author":"Schrumpf","year":"1994","journal-title":"J Hepatol"},{"key":"10.1053\/gast.2001.27965_bib10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1040420","article-title":"Relationship of inflammatory bowel disease and primary sclerosing cholangitis","volume":"11","author":"Fausa","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1053\/gast.2001.27965_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-2036.1997.91263000.x","article-title":"Review article: the management of primary sclerosing cholangitis","volume":"11","author":"Mitchell","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/gast.2001.27965_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1600-0676.2000.020002097.x","article-title":"Liver transplantation for primary sclerosing cholangitis","volume":"20","author":"Gow","year":"2000","journal-title":"Liver"},{"key":"10.1053\/gast.2001.27965_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2214\/ajr.161.2.8333366","article-title":"Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases","volume":"161","author":"Sheng","year":"1993","journal-title":"AJR"},{"key":"10.1053\/gast.2001.27965_bib15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.1840200214","article-title":"Fibrous and obliterative cholangitis in liver allografts: evidence of recurrent primary sclerosing cholangitis?","volume":"20","author":"Harrison","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib17","first-page":"711","article-title":"Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones","volume":"76","author":"Gleeson","year":"1990","journal-title":"Q J Med"},{"key":"10.1053\/gast.2001.27965_bib18","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2001.27965_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis [see comments]","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/hep.1840140516","article-title":"Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study","volume":"14","author":"O'Brien","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(90)90281-U","article-title":"Ursodeoxycholic acid for primary sclerosing cholangitis","volume":"11","author":"Chazouill\u00e9res","year":"1990","journal-title":"J Hepatol"},{"key":"10.1053\/gast.2001.27965_bib23","first-page":"A181","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis","volume":"7","author":"van-Milligen-de-Wit","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/gast.2001.27965_bib24","first-page":"511","article-title":"Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study","volume":"91","author":"Lindor","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.2001.27965_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial","volume":"16","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-8278(05)80467-2","article-title":"Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period","volume":"20","author":"Stiehl","year":"1994","journal-title":"J Hepatol"},{"key":"10.1053\/gast.2001.27965_bib27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2001.27965_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0016-5085(84)90136-7","article-title":"Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones","volume":"87","author":"von Bergmann","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jcp.48.10.933","article-title":"Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis","volume":"48","author":"Olsson","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1053\/gast.2001.27965_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1053\/gast.2001.27965_bib32","first-page":"555","article-title":"The syndrome of primary sclerosing cholangitis","volume":"9","author":"Ludwig","year":"1990","journal-title":"Prog Liver Dis"},{"key":"10.1053\/gast.2001.27965_bib33","first-page":"252","article-title":"Generalised Linear Models","author":"McCullagh","year":"1989"},{"key":"10.1053\/gast.2001.27965_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","article-title":"CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"19","author":"Bjornsson","year":"1999","journal-title":"Liver"},{"key":"10.1053\/gast.2001.27965_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1572-0241.2000.01685.x","article-title":"The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis","volume":"95","author":"Patel","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.2001.27965_bib36","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/gast.2001.27965_bib38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0016-5085(94)90027-2","article-title":"Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts","volume":"106","author":"Heuman","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/hep.1840220113","article-title":"Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture","volume":"22","author":"Hillaire","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.1840120307","article-title":"Ursodeoxycholic acid reduces hepatotoxicity of bile salts in primary human hepatocytes","volume":"12","author":"Galle","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib41","first-page":"145","article-title":"Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line","volume":"19","author":"Strazzabosco","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.1840150421","article-title":"Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease","volume":"15","author":"Colombo","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib43","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0022-2275(20)38207-9","article-title":"Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment","volume":"30","author":"Batta","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1053\/gast.2001.27965_bib44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/0016-5085(92)90162-R","article-title":"Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage","volume":"102","author":"Walker","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib45","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hep.1840120521","article-title":"Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man","volume":"12","author":"Marteau","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib46","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/gut.32.9.1044","article-title":"Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test","volume":"32","author":"Eusufzai","year":"1991","journal-title":"Gut"},{"key":"10.1053\/gast.2001.27965_bib47","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0168-8278(05)80284-3","article-title":"Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis","volume":"18","author":"Kurktschiev","year":"1993","journal-title":"J Hepatol"},{"key":"10.1053\/gast.2001.27965_bib49","first-page":"A595","article-title":"The effect of ursodeoxycholic acid in primary sclerosing cholangitis. A comparison to primary biliary cirrhosis","volume":"94","author":"Stiehl","year":"1988","journal-title":"Gastroenterology"},{"issue":"suppl 12","key":"10.1053\/gast.2001.27965_bib50","doi-asserted-by":"crossref","first-page":"59S","DOI":"10.1007\/BF01536665","article-title":"Effect of different doses of ursodeoxycholic acid in chronic liver disease","volume":"34","author":"Podda","year":"1989","journal-title":"Dig Dis Sci"},{"key":"10.1053\/gast.2001.27965_bib51","first-page":"A602","article-title":"Treatment of primary sclerosing cholangitis with ursodexoycholic acid: first results of a controlled study","volume":"10","author":"Stiehl","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib52","first-page":"A966","article-title":"The effect of ursodeoxycholic acid treatment in primary sclerosing cholangitis: results of a pilot study","volume":"104","author":"O'Brien","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib53","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","article-title":"Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study","volume":"26","author":"Stiehl","year":"1997","journal-title":"J Hepatol"},{"key":"10.1053\/gast.2001.27965_bib54","first-page":"62A","article-title":"Ursodeoxycholic acid therapy for primary sclerosing cholangitis: preliminary report of a randomized controlled trial","volume":"16","author":"Van-Thiel","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib55","first-page":"A1352","article-title":"Single versus three times daily ursodeoxycholic acid for primary sclerosing cholangitis: results of a randomized controlled trial","volume":"110","author":"Van Hoogstraten","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib56","first-page":"92A","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: a double-blind placebo controlled trial (abstr)","volume":"16","author":"Lo","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/gast.2001.27965_bib57","first-page":"283","article-title":"Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment","volume":"23","author":"Stiehl","year":"1995","journal-title":"J Hepatol"},{"key":"10.1053\/gast.2001.27965_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01211187","article-title":"Effects of ursodeoxycholic acid and chenodeoxycholic acid on major histocompatibility complex class I gene expression","volume":"31","author":"Hirano","year":"1996","journal-title":"J Gastroenterol"},{"key":"10.1053\/gast.2001.27965_bib59","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1111\/j.1572-0241.1999.01543.x","article-title":"The time course of histological progression in primary sclerosing cholangitis","volume":"94","author":"Angulo","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.2001.27965_bib60","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/0016-5085(92)90345-Y","article-title":"Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis","volume":"102","author":"Lebovics","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2001.27965_bib61","first-page":"1957","article-title":"Radiologic regression of primary sclerosing cholangitis following combination therapy with an endoprosthesis and ursodeoxycholic acid","volume":"88","author":"Springer","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/gast.2001.27965_bib62","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00042737-199706000-00005","article-title":"Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques","volume":"9","author":"Bansi","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508501599850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508501599850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T06:01:33Z","timestamp":1626242493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508501599850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0016508501599850"],"URL":"https:\/\/doi.org\/10.1053\/gast.2001.27965","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}